CARDONE, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 363
AS - Asia 207
NA - Nord America 144
SA - Sud America 13
Totale 727
Nazione #
RU - Federazione Russa 294
US - Stati Uniti d'America 141
SG - Singapore 83
CN - Cina 48
HK - Hong Kong 31
IT - Italia 30
IE - Irlanda 20
VN - Vietnam 15
DE - Germania 11
BR - Brasile 10
IN - India 10
KR - Corea 8
JP - Giappone 4
CA - Canada 3
NL - Olanda 3
EC - Ecuador 2
PL - Polonia 2
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
PH - Filippine 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 727
Città #
Moscow 105
Singapore 42
San Jose 34
Hong Kong 29
Santa Clara 21
Dublin 18
Ashburn 12
Beijing 9
Hefei 9
Chandler 8
Seoul 8
Hanoi 7
Naples 7
New York 7
Dallas 6
Bengaluru 5
Los Angeles 5
Aversa 4
Munich 4
Amsterdam 3
Ho Chi Minh City 3
Sant'Antimo 3
Atlanta 2
Berlin 2
Bremen 2
Brooklyn 2
Cambridge 2
Giugliano in Campania 2
Hyderabad 2
Montreal 2
Princeton 2
Rome 2
Roxbury 2
Shanghai 2
São Paulo 2
Warsaw 2
Amman 1
Baku 1
Bishkek 1
Bologna 1
Brno 1
Cali 1
Cascavel 1
Cercola 1
Chengdu 1
Chennai 1
Council Bluffs 1
Da Nang 1
Des Moines 1
El Paso 1
Falkenstein 1
Florence 1
Guangzhou 1
Guayaquil 1
Haikou 1
Houston 1
Iporá 1
João Pessoa 1
Kayseri 1
Limburg an der Lahn 1
Manado 1
Manchester 1
Milan 1
Mumbai 1
New Delhi 1
Newark 1
Oeiras 1
Orem 1
Petersburg 1
Ponta Porã 1
Pozzuoli 1
Poções 1
Qingdao 1
Riyadh 1
San Diego 1
Secaucus 1
Seropédica 1
St Petersburg 1
São Bernardo do Campo 1
Taiyuan 1
The Dalles 1
Thái Nguyên 1
Tokyo 1
Toronto 1
Vienna 1
Yuen Long 1
Totale 427
Nome #
Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial 159
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 145
Pimasertib hydrochloride 143
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 135
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 129
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer 29
Totale 740
Categoria #
all - tutte 2.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 4 3 0 0 2 1 4
2022/202332 3 0 1 1 6 2 0 2 12 0 3 2
2023/202430 3 0 1 0 7 6 3 2 1 0 2 5
2024/2025114 2 3 0 14 18 16 18 14 10 5 3 11
2025/2026550 18 26 25 10 42 277 30 33 30 16 31 12
Totale 740